论文部分内容阅读
目的观察<6h的早期心肌梗死(AMI)冠状动脉再通及其他辅助治疗对急性AMI伴心源性休克患者转归的影响,探讨最佳治疗方案。方法对前壁AMI伴心源性休克的30例患者进行回顾性研究。结果 30例患者均接受溶栓治疗,溶栓后分为药物组(14例)和介入组(16例)。药物组家属拒绝介入治疗,给予血管活性药物;介入组行冠脉造影术、行经皮冠状动脉腔内成形术、支架术、主动脉内球囊反搏、呼吸机辅助呼吸等治疗。药物组患者住院期间死亡11例,病死率为78.6%。介入组死亡5例,病死率为31.3%,较药物组明显降低(P<0.01)。结论溶栓后早期冠状动脉再通可降低急性心肌梗死伴心源性休克的病死率。
Objective To observe the effect of coronary revascularization and other adjuvant therapy of early myocardial infarction (AMI) <6h on the outcome of acute AMI patients with cardiogenic shock and to explore the best treatment plan. Methods A retrospective study was performed on 30 patients with anterior myocardial amyloidosis with cardiogenic shock. Results Thirty patients received thrombolytic therapy. After thrombolysis, they were divided into medication group (n = 14) and intervention group (n = 16). Family members refused to intervene in the treatment group, given vasoactive drugs; interventional group coronary angiography, percutaneous transluminal coronary angioplasty, stenting, intra-aortic balloon pump, ventilator-assisted breathing and other treatment. In the drug group, 11 patients died during hospitalization and the case fatality rate was 78.6%. In the intervention group, 5 cases died, the case fatality rate was 31.3%, which was significantly lower than that in the drug group (P <0.01). Conclusion The early reperfusion of coronary artery after thrombolysis can reduce the mortality of acute myocardial infarction with cardiogenic shock.